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ABSTRACT 
Jab1, also known as Csn5/Cops5, is a key subunit of the COP9 Signalosome, a highly 
conserved macromolecular complex. We previously reported that the conditional knockout of 
Jab1 in mouse limb buds and chondrocytes results in severely shortened limbs and neonatal 
lethal chondrodysplasia, respectively. In this study, we further investigated the specific role 
of Jab1 in osteoblast differentiation and postnatal bone growth by characterizing a novel mouse 
model, the Osx-cre; Jab1
flox/flox
 conditional knockout (Jab1 cKO) mouse, in which Jab1 is 
deleted in osteoblast precursor cells. Jab1 cKO mutant mice appeared normal at birth, but 
developed progressive dwarfism. Inevitably, all mutant mice died prior to weaning age. The 
histological and micro-computed tomography analysis of mutant long bones revealed severely 
altered bone microarchitecture, with a significant reduction in trabecular thickness. Moreover, 
Jab1 cKO mouse tibiae had a drastic decrease in mineralization near the epiphyseal growth 
plates, and Jab1 cKO mice also developed spontaneous fractures near the tibiofibular junction. 
Additionally, our cell culture studies demonstrated that Jab1 deletion in osteoblast precursors led 
to decreased mineralization and a reduced response to TGFβ and BMP signaling. Moreover, an 
unbiased reporter screen also identified decreased TGFβ activity in Jab1-knockdown osteoblasts. 
Thus, Jab1 is necessary for proper osteoblast differentiation and postnatal bone growth, likely in 
part through its positive regulation of the TGFβ and BMP signaling pathways in osteoblast 
progenitor cells. 
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Bone homeostasis is a lifelong process in which bone is remodeled by the concerted 
actions of bone forming osteoblasts and bone resorbing osteoclasts (1). Moreover, osteoblast 
derived osteocytes are mechanosensors that coordinate the activity of osteoblasts and osteoclasts 
(1). Osteoblasts also play essential roles in regulating hematopoietic cells in the bone marrow 
(2). Many signaling pathways are crucial for proper bone development and homeostasis, 
especially the Transforming Growth Factor β (TGFβ) and Bone Morphogenetic Protein (BMP) 
signaling pathways (3, 4). Canonical TGFβ/BMP signaling is transduced through downstream 
effector R-Smads, Smad2/3 (TGFβ) and Smad1/5/8 (BMP). The activation of R-Smads is 
mediated by a ligand binding induced dimerization of Type I and Type II TGFβ or BMP 
receptors, resulting in phosphorylation and activation of the R-Smads. Activated R-Smads then 
bind with Smad4, and translocate to the nucleus to promote transcription of TGFβ/BMP target 
genes (3, 4). The TGFβ/BMP signaling pathway is evolutionarily conserved in metazoans and 
plays many crucial roles in bone and cartilage development and homeostasis. TGFβ/BMP 
dysregulation results in various osteochondrodysplasias and other diseases, including cancer (4). 
 Jab1, also known as Cops5/Csn5, is an essential component of the evolutionarily 
conserved COP9 Signalosome (CSN) complex (5). Jab1 is the only CSN subunit that harbors a 
JAMM (Jab1/MPN/Mov34 metalloenzyme) motif necessary for the enzymatic removal of 
NEDD8 (deNEDDylation), a small, ubiquitin-like protein, from the Cullin subunit of the Cullin-
RING Ligases (CRLs), largest family of E3 ubiquitin ligases (5). The CSN complex is required 
for animal survival, which is highlighted by the fact that the knockout of any individual CSN 
subunit in mice so far all result in early embryonic lethality (6, 7). Interestingly, Jab1 was also 
independently identified as a co-activator of c-Jun and JunD (8). Outside of the CSN complex, 
Jab1 also plays a versatile role in regulating the localization, stability, and activity of many 
transcription factors, including p53, HIF-1α, AP-1 family members, and various Smads (8-13). 
Thus, Jab1 is essential for regulating many cellular functions, including differentiation, 
apoptosis, proliferation, DNA damage response, and numerous signal transduction pathways (7). 
Our lab previously demonstrated that Jab1 is necessary for the successive stages of mouse 
skeletogenesis during embryogenesis, likely through regulating the TFGβ/BMP signaling 
pathways in a context-specific manner (14, 15). Prx1-cre-mediated deletion of Jab1 specifically 
in osteochondral progenitor cells of the limb buds resulted in severely shortened limbs at birth 
with a drastically disorganized epiphyseal growth plate, impaired osteoblastogenesis, decreased 
chondrogenesis, and a reduced response to BMP signaling (15). On the other hand, the 
chondrocyte-specific deletion of Jab1 using a Col2a1-cre driver resulted in severe 
chondrodysplasia and neonatal lethality, with a severe growth plate defect (14). Col2a1-cre; 
Jab1
flox/flox
 chondrocytes displayed increased apoptosis, impaired cell cycle progression, and 
increased expression of BMP signaling effectors (14). Thus, Jab1 is necessary for proper skeletal 
development during mouse embryogenesis, at least in part through its regulation of BMP 
signaling activity, in a stage-specific manner. However, the specific role of Jab1 in osteoblast 
progenitor cells and postnatal bone growth was unknown until this study. 
Thus, to investigate the role of Jab1 in bone homeostasis, we deleted Jab1 in osteoblast 
precursor cells using the Osx1-GFP::Cre (hereafter referred to as Osx-cre) deleter (16). 
Interestingly, while the Osx-cre; Jab1
flox/flox
 conditional knockout (cKO) mice appeared normal 
at birth, they then all developed progressive dwarfism. Surprisingly, Jab1 cKO mice died with 
100% penetrance prior to weaning age. Histological and micro-computed tomography (µCT) 
analyses revealed that these mice have significantly decreased postnatal bone growth, a delayed 
secondary ossification center formation, and severely altered bone microarchitecture. 
Furthermore, there is impaired osteoblast differentiation and mineralization, concomitant with a 
reduced response to TGFβ/BMP signaling in Jab1 cKO osteoblast precursor cells.  
 
2. Materials and Methods 
2.1 Mouse Studies  
All animal protocols were approved by the IACUC of Case Western Reserve University. 
All mice were maintained and housed at Case Western Reserve University’s animal facility 
under standard conditions, as in previous studies (14, 15). The Jab1
flox/flox
 mice were obtained 





were purchased from The Jackson Laboratory (Stock No. 006361 and 003309, respectively).  
2.2 Cell Culture  
  The osteoblast precursor cell line MC3T3-E1 (CRL-2593) and mouse bone marrow 
stromal cell (mBMSC) (CRL-12424) lines were purchased from ATCC (Manassas, VA, USA) 
and were cultured according to the manufacturer’s instructions. For lentiviral infection, MC3T3-
E1 and mBMSCs cells were infected with Mission shRNAs (Sigma-Aldrich, St. Louis, MO, 
USA) specifically targeting Jab1 (shRNAs 1, 2, and 3 correspond to TRCN0000304598, 
TRCN0000311065, and TRCN0000302049, respectively) or a Non-Mammalian shRNA control 
(SHC002V) at MOI = 3 (MC3T3-E1 cells) or MOI = 5 (mBMSCs cells) per the manufacturer’s 
protocol (19). 48 hours after infections, cells were selected using puromycin at concentrations of 
3.5µg/mL or 6µg/mL for MC3T3-E1 and mBMSCs, respectively. The Cignal Finder Reporter 
Array #CCA-901L-12 (Qiagen) was used to measure signal transduction pathway reporter 
activities according to the manufacturer’s protocol as previously described (19). Briefly, the 
control and Jab1-knockdown MC3T3-E1 cells were reverse transfected by plating into 96-well 
plates, and signal pathway reporter activities were measured using the dual luciferase assay kit 
(Promega, Madison, WI, USA) according to the manufacturer’s protocol.  
Primary mouse calvarial osteoblasts were isolated from P5 Jab1
flox/flox
 mice by serial 
Collagenase P digestions, and expanded for 48hrs, as previously described (20). Cells were then 
infected with adenoviruses expressing either Cre Recombinase (Ad-Cre) or Green Fluorescent 
Protein (Ad- GFP) (Gene Transfer Vector Core) at MOI = 500, and analyzed as previously 
described (14, 15). Osteoblast differentiation was induced by culturing cells in α-MEM 
supplemented with 5 mM β-Glycerophosphate and 100µg/mL ascorbic acid for 21 days, as 
previously described (20).  
2.3 Western Blotting  
Total proteins were extracted from MC3T3-E1 cells and mBMSCs in RIPA buffer 
(Thermo Fisher Scientific, Waltham, MA, USA), or from mouse primary calvarial osteoblasts in 
5% SDS, and supplemented with Halt Protease and Phosphatase Inhibitor Cocktail (Thermo 
Fisher Scientific). Subsequent western blotting was performed as previously described (14, 15, 
19). The antibodies used in this study are listed in Supplementary Table S1. 
2.3 RNA Isolation, cDNA Synthesis, and Real-Time Quantitative RT-PCR  
Total RNAs were isolated from MC3T3-E1 cells and primary calvarial osteoblasts using 
TRIzol reagent (Invitrogen) and the PureLink RNA Mini kit (Ambion, Foster City, CA, USA) as 
previously described (14, 15, 19). The primers in this study are listed in Supplementary Table 
S2.  
2.4 Histology 
The entire P18 mouse hindlimbs were separated from the pelvis, placed into a cassette 
with the lateral side down, and fixed for 16 hrs in 10% neutral buffered formalin. After 3 washes 
of PBS, the hindlimbs were decalcified in 0.5M EDTA for 21 days. Tissues were then embedded 
in paraffin, sectioned at 5µm thickness, and stained with H&E as previously described (14, 15, 
19, 21).  Von Kossa staining (22), Oil Red O Staining, (23), and β-galactosidase staining (24) 
was performed as previously described. 
2.5 Micro-Computed Tomography (µCT) 
Whole tibiae were excised from P18-P20 mice and fixed in 10% neutral buffered 
formalin for 16 hrs. After 3 washes in PBS, the samples were stored in 70% ethanol at 4°C. Prior 
to µCT analysis, tibiae were first rehydrated in PBS containing calcium and magnesium to 
minimize mineral dissolution (25). Scans were conducted in a Bruker SkyScan1172 (Bruker 
MicroCT, Kontich, Belgium) with a 11 MPix camera at an isotropic voxel size of 8µm 
employing a 0.5mm thick aluminum filter. An applied x-ray tube voltage of 50kV with an x-ray 
intensity of 100µA was applied over 180 degrees of rotation with acquisition every 0.45 degrees. 
Reconstruction was carried out with a modified Feldkamp algorithm (26) using the SkyScan 
NRecon software accelerated by GPU (27). Tibial reconstruction alignments were adjusted with 
SkyScan DataView software to a consistent orientation. The selection of the Region/volume of 
interest (ROI/VOI), the segmentation to binary, and the morphometric analysis were all 
performed using SkyScan CT-Analyser (“CTAn”) software. Morphometry measurements for 
both cortical and trabecular bone were based on previously reported guidelines (28). Tibial 
lengths were measured from proximal to distal epiphyses. The cortical VOI was defined as 
0.5mm (62 slices) beginning 10 slices proximally offset (0.08mm) from 58% of the metaphysis-
metaphysis length, which is the mean position of the tibia-fibula junction (TFJ) in wild type 
mice. At this age, the proximal metaphysis does not have a clear cortical-trabecular separation 
(29). Therefore, the entire proximal metaphysis was analyzed for 3D trabecular morphometry. 
Due to significant size differences among genotypes, the analysis of trabecular VOI was defined 
as 25% of the metaphysis-metaphysis length.  
2.6 Statistical Analysis  
All experiments were conducted using at least 3 biological replicates. Data are expressed 
as mean ± standard deviation. With the exception of µCT data, all statistical analysis was 
performed using a 2-tailed Student’s t-test on normally distributed data, with p < 0.05 considered 
significant. Statistical tests on µCT data were performed with GraphPad Prism version 8.4.2 
software (GraphPad Software, La Jolla, CA, USA). Data were assessed using D’Agostino & 
Pearson normality testing and Brown-Forsythe test for Equal Variance.  Normally distributed 
data exhibiting equal variance were analyzed by one-way ANOVA with post-hoc analysis by 
Bonferroni’s multiple comparisons test. Data that were not normally distributed or displaying 
equal variance were tested by Kruskal-Wallis one-way ANOVA with post-hoc analysis by 
Dunn’s multiple comparisons test.   
 
3. Results 
3.1. The loss of Jab1 in osteoblast progenitor cells results in a progressive postnatal dwarfism 
phenotype and early lethality. 
To investigate the specific role of Jab1 in postnatal bone growth, we deleted Jab1 
specifically in osteoblast precursor cells with a commonly used Osx-cre deleter to generate Osx-
cre; Jab1 
flox/flox
 (Jab1 cKO) mice (16). To confirm the cells targeted by the Osx-cre transgene, 
we first crossed Osx-cre only mice with Rosa26-LacZ mice. The β-galactosidase staining of long 
bones from Osx-cre; Rosa26-LacZ mice revealed the expression of Osx-cre in osteoblasts lining 
the diaphyseal periosteum, the trabecular bone, the secondary ossification center, and also in the 
hypertrophic chondrocytes and osteocytes, as previously reported (30, 31) (Figure S1). It was 
previously reported that the expression of the Osx-cre transgene alone might result in a minor 
bone phenotype in mice (30, 32, 33). Thus, in this study, we performed all mouse experiments 
using Osx-cre only mice as controls, in addition to wild type controls.  
Both Jab1 cKO and Osx-cre only mice appeared grossly normal at birth and through 6 
days of age. By 7 days of age, both Osx-cre only and Jab1 cKO mice begin to develop dwarfism. 
Our results are in agreement with previous studies showing a decrease in the length and weight 
of Osx-cre only mice at around 1 week of age (30, 33). However, whereas the Osx-cre only mice 
have a normal lifespan/healthspan, and their length stabilizes thereafter, the dwarfism in Jab1 
cKO mice progressively worsened and they also began to appear lethargic around postnatal day 
12 (Figure 1A). Unexpectedly, all Jab1 cKO mice die by postnatal day 21, around their weaning 
age. Indeed, Jab1 cKO mice had significantly decreased body length and weight by postnatal day 
18 compared with wild type mice and Osx-cre only controls (Figure 1B). These results 
demonstrate that the expression of Jab1 in osteoblast precursor cells is essential for survival and 
for maintaining normal postnatal growth in mice.  
 
3.2. The loss of Jab1 in osteoblast precursors drastically alters trabecular and cortical bone 
structure and delays the formation of the secondary ossification center.  
Next, we collected tibiae from 18-21-day old wild type, Osx-cre only, and Jab1 cKO 
mice to identify the overall differences in bone structure of early postnatal bones. Histological 
analysis revealed that the primary trabeculae in Jab1 cKO mice are thinner compared with wild 
type and Osx-cre only mice (Figure 2A). Proper secondary ossification center formation is 
critical for growth plate formation and long bone growth. Interestingly, our histological analysis 
also revealed that the secondary ossification center in Jab1 cKO mice was much smaller than 
both the wild type and Osx-cre only mice (Figure 2B). This might be due to a delay in the initial 
formation of the SOC, as the histology at postnatal day 9 shows a drastically decreased size of 
the secondary ossification center in Jab1 cKO, which persists through postnatal day 16 (Figure 
S2). The histology also uncovered that the cortical bone is more porous in Jab1 cKO mice 
compared with Osx-cre only and wild type mice (Figure 2C). Thus, Jab1 expression in osteoblast 
precursor cells is critical for proper secondary ossification center formation and proper bone 
growth. 
 
3.3. Jab1 deficiency in osteoblast precursor cells severely impairs bone microarchitecture. 
To further characterize the in vivo effect of Jab1 loss on postnatal bone growth, we 
performed detailed micro-computed tomography (µCT) analysis on the tibiae of 18-21-day-old 
wild type, Osx-cre only, and Jab1 cKO mice. Representative reconstructions of tibiae from each 
genotype are presented in Figure 3A. First of all, we observed some heterogeneity among 
individual samples of Jab1 cKO tibiae (Figure S3). Nonetheless, in agreement with the length 
measurements of the entire mouse (Figure 1B), µCT reconstructions and quantification of the 
tibial length confirmed that Jab1 cKO mice had significantly shorter tibiae compared with wild 
type and Osx-cre only mice (Figures 3A and 3B). Next, µCT quantification revealed that both 
the periosteal and endosteal perimeter were significantly decreased in Jab1 cKO mutants, 
indicating decreased bone size (Figure S4). Moreover, similarly to our histological analysis, the 
µCT analysis revealed that the primary trabecular bone in Jab1 cKO and Osx-cre only mice 
appeared to be decreased when compared with wild type mice (Figure 3A, third row, and Figure 
S5A). Indeed, uCT quantification of trabecular bone confirmed that there were significant 
decreases in the trabecular thickness of Jab1 cKO and Osx-cre only tibiae compared with wild 
type tibiae. There was also a trend towards increased trabecular separation in Jab1 cKO bones 
compared with Osx-cre only and wild type bones (Figure 4A). Additionally, uCT quantification 
of trabecular bone volume (BV) and total volume (TV) revealed a significant decrease in Jab1 
cKO tibiae compared with wild type tibiae, as expected based on the smaller size of Jab1 cKO 
mice (Figures 1A and 4B). We also observed a trend towards decreased BV and TV in the tibiae 
of Jab1 cKO mice when compared with Osx-cre only mice (Figure 4B). However, due to the 
proportional decrease in both bone volume and tissue volume within genotypes, the bone volume 
fraction (BV/TV) was not significantly changed among Jab1 cKO, Osx-cre only, and wild type 
controls (Figure 4B). Furthermore, uCT analysis demonstrates that the cortical bone was thicker 
in both Jab1 cKO and Osx-cre only tibiae compared with wild type (Figures 3A, 5A, and S5B). 
Furthermore, when compared with wild type tibiae, the cortical bone area (BA) was either 
slightly decreased in Jab1 cKO or was similar in Osx-cre only tibiae. There were also decreases 
in the total cross sectional area (TA) in Jab1 cKO and Osx-cre only tibiae compared with wild 
type tibiae. Thus, when compared with wild type, there was a significantly increased cortical 
bone area fraction (BA/TA) in Osx- cre only mice, which was exacerbated in Jab1 cKO mice 
(Figure 5B). Interestingly, cross sections of cortical bone appeared to be more porous in Jab1 
cKO and Osx-cre only bones compared with wild type bones, similarly to our histological 
analysis (Figures 2C and 3A, bottom row). 
Intriguingly, in some Jab1 cKO bones, a large portion of their proximal and distal ends 
appeared to be poorly mineralized (Figure 3C), even though gross examinations showed that 
there were tissues present in these areas. We also observed that multiple Jab1 cKO mice had 
callus-like structures present near their distal tibiofibular junction (Figures 3A, 3D, and S3). In 
contrast, no similar callus-like structures were ever identified in any of the tibiae isolated from 
wild type or Osx-cre only mice (Figure S3). A closer examination of this callus-like structure in 
Jab1 cKO tibiae revealed that the area inside this callus-like structure was likely to be newly 
formed bone (Figure 3D). This finding suggests that Jab1 cKO bones might be more susceptible 
to incurring spontaneous fractures compared with wild type and Osx-cre only bones. Therefore, 
the loss of Jab1 in osteoblast precursors significantly alters long bone microarchitecture, impairs 
proper mineralization, and might lead to spontaneous fractures.   
  
3.4. The loss of Jab1 in osteoblast precursors inhibits osteoblast differentiation and 
mineralization, likely in part through the positive regulation of TGFβ/BMP signaling.  
Our previous study in Prx1-cre; Jab1
flox/flox
 mice showed that Jab1 positively regulates 
BMP signaling in osteochondral progenitor cells (15). Thus, we hypothesized that the loss of 
Jab1 specifically in osteoblast precursor cells also results in impaired BMP-mediated osteoblast 
differentiation and mineralization. To this end, we first knocked down Jab1 expression in 
primary calvarial osteoblasts isolated from Jab1
flox/flox
 mice, using adenoviruses expressing either 
Cre Recombinase (Ad-Cre) or, as a control, a GFP reporter (Ad-GFP) (14, 15). We first 
confirmed the Jab1 knockdown efficiency at the RNA and protein levels (Figure 6A). Next, we 
cultured the primary osteoblasts in osteoblast differentiation media for 21 days and examined 
mineralization status by performing Von Kossa staining (Figure 6A). Von Kossa staining 
revealed fewer black nodules in Jab1-knockdown versus control primary osteoblasts, indicating 
that Jab1 is required for robust osteoblast differentiation and mineralization. To confirm this 
finding, we also performed Jab1-knockdown experiments in a widely used mouse 
preosteoblastic cell line, MC3T3-E1 (34), using lentiviral shRNAs specifically targeting Jab1. 
Again, von Kossa staining revealed that the depletion of Jab1 expression nearly abolished nodule 
formations in MC3T3-E1 cells as well (Figure 6B). Together, these results confirm that Jab1 
deficiency drastically reduced osteogenic potential in osteoblast precursor cells, which may 
account for the impaired mineralization and altered bone structure observed in our histological 
and µCT analyses of Jab1 cKO mice (Figures 2 and 3).  
Mesenchymal stem cells (MSCs) are multipotent cells with the ability to differentiate into 
multiple mesenchymal cell lineages, including osteoblasts and adipocytes (35). It is also well-
established that the loss of osteogenic differentiation is often associated with an increased 
adipogenic potential (35). Thus, to determine the effect of Jab1 loss on MSC adipogenesis, we 
performed a lentiviral Jab1-knockdown in a mouse bone marrow stromal cell (mBMSC) line, 
and then induced them to differentiate into adipocytes (Figure 6C). Indeed, we found that there 
were increased lipid droplets in mBMSCs by Oil Red O staining in Jab1-knockdown mBMSCs. 
Thus, the loss of Jab1 might lead to an increase in adipogenic potential and decreased osteoblast 
differentiation and mineralization.  
To further explore the underlying mechanism of Jab1-mediated osteoblast differentiation, 
we next examined the expression of a master osteoblast differentiation transcription factor Runx2 
upon Jab1-knockdown in osteoblast precursor cells (36). Interestingly, we found that the loss of 
Jab1 in MC3T3-E1 cells resulted in no significant change in the Runx2 expression at either the 
RNA or protein level (Figure 7A and 7B). However, we detected a significant decrease in the 
mRNA expression of Osteocalcin, the most specific late-stage marker of osteoblast 
differentiation, in Jab1-knockdown MC3T3-E1 cells (Figure 7A). This finding is consistent with 
the mineralization defect we observed in Jab1 cKO mice (Figures 3C), indicating that the loss of 
Jab1 in osteoblast precursors might lead to a late-stage differentiation defect. Next, to determine 
the effect of Jab1 loss on major signaling pathways, we performed an unbiased reporter screen in 
MC3T3-E1 cells (Figure 7C). Impressively, we found that of 45 major signaling pathway 
reporters, 31 (68%) of them were clearly altered in MC3T3-E1 cells upon Jab1-knockdown 
(Figure 7C). Furthermore, of those 31 reporters, 26 (83%) were downregulated, including a 
Smad2/3 reporter for the TGFβ pathway (Figure 7C). All together, these data are consistent with 
the established function of Jab1 as a transcriptional co-factor and with others’ previous reports 
demonstrating a link between Jab1 and the TGFβ/BMP signaling pathway (8, 11, 12, 14, 15, 37-
39).  
TGFβ is crucial for many aspects of bone biology and osteoblast differentiation, and is 
tightly regulated at many levels. Therefore, we decided to further investigate the effect of Jab1 
loss on osteoblast’s response to TGFβ/BMP stimulation. When primary mouse calvarial 
osteoblasts were cultured in osteoblast differentiation media for 21 days, Jab1 was expressed at 
both an early (Day 0) and a late stage (Day 21) of osteoblast differentiation (Figure 7D), hinting 
that Jab1 is required throughout osteoblast differentiation. We also observed a higher level of 
phospho-Smad1/5/8, a key downstream BMP effector, at Day 21 versus Day 0 (Figure 7D). 
Next, we infected primary calvarial osteoblasts isolated from Jab1
flox/flox
 mice with adenoviruses 
expressing either Cre Recombinase (Ad-cre) or a GFP control (Ad-GFP), induced them to 
differentiate into osteoblasts, and performed western blotting for phospho-Smad1/5/8 (Figure 
7E). Interestingly, we found that a decrease in the levels of Jab1 resulted in a major decrease in 
the levels of phospho-Smad1/5/8 in primary osteoblasts (Figure 7E).  Furthermore, we treated 
control and Jab1-knockdown MC3T3-E1 preosteoblasts with BMP7 (300ng/mL) or TGFβ-3 
(2ng/mL), and determined the expressions of phospho-Smad1/5/8 and phospho-Smad2/3, a key 
TGFβ downstream effector, respectively (Figure 7F). Indeed, there was a decreased response to 
both TGFβ and BMP signaling upon Jab1-knockdown in MC3T3-E1 cells. These results suggest 
that Jab1 promotes osteoblast differentiation and mineralization at least in part through 
stimulating TGFβ/BMP signaling.  
 
4. Discussion 
Jab1 is an essential subunit of the COP9 Signalosome, and regulates many vital cellular 
functions, including cell proliferation, differentiation, and apoptosis. Indeed, the conditional 
knockout of Jab1 in any given tissue studied to date all results in severe defects to progenitor cell 
survival and differentiation (5). Our previous work has demonstrated that, as a master 
developmental regulator, Jab1 is necessary for the successive stages of skeletogenesis by 
regulating the TGFβ/BMP signaling pathways in a context-specific manner (14, 15). Interestingly, 
master developmental regulators are often reactivated during tumorigenesis to promote 
malignancy via their specific effects on cell proliferation, differentiation, and survival. Indeed, as 
a potential oncogene, JAB1 has been shown to be overexpressed in many different forms of 
cancer (7). To that end, we have recently demonstrated that JAB1 overexpression specifically in 
osteoblasts can increase the incidence of p53-dependent osteosarcoma formation in mice (19). 
Moreover, a recently developed small molecular inhibitor of JAB1, CSN5i-3,  has shown 
promising results in reducing cell viability, including in osteosarcoma (19). Therefore, a better 
understanding of the physiological role of Jab1 in osteoblasts will facilitate the development of 
better Jab1-targeted therapeutic options for osteosaercoma and other cancers.  
In the present study, we provide strong evidence that the expression of Jab1 in osteoblast 
precursor cells is essential for proper postnatal bone growth and osteoblast differentiation in mice, 
likely at least in part through the regulation of TGFβ/BMP signaling. To our knowledge, whereas 
dwarfism and impaired bone structure is relatively common in mice in which a gene of interest is 
deleted using the the same Osx-cre driver, early postnatal lethality is extremely rare among them. 
Very strikingly, Jab1 cKO mutant mice all die around weaning age. While the Osx-cre transgene 
mainly targets cells at the earliest stages of osteoblast differentiation, it is also known to target 
some other cell types, including hypertrophic chondrocytes, osteocytes, stromal cells, and 
perivascular cells (30, 31). Indeed, our β-galactosidase staining in Osx-cre; Rosa26 LacZ tibiae 
revealed strong LacZ expressions in osteoblasts, as well as osteocytes and hypertrophic 
chondrocytes (Figure S1). Because osteoblasts constitute a major component of the hematopoietic 
stem cell niche (2), we speculate that the early lethality in Jab1 cKO mice might result from 
defective hematopoiesis. Interestingly, a recent study demonstrated that Osx-cre-mediated 
deletion of Tgfbr2 resulted in early lethality at 4-weeks of age, dwarfism, reduced osteoblast 
maturation, and perturbed hematopoiesis (40). Additionally, Jab1 has been linked to 
hematopoietic defects in mice (41, 42). Thus, the early lethality of Jab1 cKO mice might be the 
result of defective hematopoiesis, through the regulation of the HSC niche and/or through 
TGFβ/BMP signaling, which warrants further investigation. 
Osx-cre transgenic mice by themselves were reported to have a transient dwarfism 
phenotype (30, 33). However, despite our study corroborating the finding that Osx-cre only mice 
are smaller beginning at P7, the Jab1 cKO mice were still significantly smaller than Osx-cre only 
mice at postnatal day 18 (Figures 1 and 3A). It is also important to note that the expression of the 
Osx-cre transgene by itself did not affect osteoblast differentiation (33), thus the bone defects 
observed in the Jab1 cKO mice were most likely due to the effect of Jab1 deletion. Indeed, the 
bone defects observed in some Jab1 cKO mice were so severe that the mineralization could not 
even be detected by µCT, and spontaneous fractures occurred (Figure S3). Thus, based on the 
early lethality, significantly shorter stature, multiple bone defects, and changes in most µCT 
parameters, we conclude that Jab1 plays an essential role in maintaining proper bone 
microarchitecture in mice. 
In contrast to what we previously reported in mice with Jab1 deleted specifically in 
chondrocytes, where we found an enhanced response to exogenous BMP treatment (14), the loss 
of Jab1 in osteoblast progenitor cells resulted in a reduced response to BMP treatment, 
highlighting the context-specific role of Jab1 in the regulation of key developmental signaling 
pathways. Indeed, Jab1 has been reported to positively and negatively regulate TGFβ/BMP 
signaling through controlling the stability and degradation of Smad7 and Smad4, respectively 
(11, 12). Moreover, several studies have shown that Jab1 inhibits BMP signaling by negatively 
regulating Smad1/5 (14, 37, 43). As the TGFβ/BMP signaling pathway is tightly regulated at 
multiple levels (4, 44), the role of Jab1 in regulating TGFβ/BMP signaling during skeletal 
development is likely to be highly context-dependent, and remains to be further investigated. 
Our reporter assay indicates that Jab1 activates many signal transduction pathways in 
osteoblasts. Notably, a canonical Smad2/3 TGFβ reporter activity decreased upon Jab1 deletion, 
and the response to exogenous TGFβ/BMP stimulation was also reduced in osteoblasts. 
Moreover, in both primary calvarial osteoblasts and preosteoblastic MC3T3-E1 cells, the 
mineralization was greatly reduced upon loss of Jab1 (Figure 6). Additionally, we provide 
evidence that the loss of Jab1 resulted in a shift from osteoblastogenesis to adipogenesis in 
mouse bone marrow stromal cells. It is well-established that low bone mass can result from a 
lineage shift in mesenchymal stem cells from osteoblasts to adipocytes, which can contribute to 
osteoporosis (45). Thus, a better understanding of the role of Jab1 in promoting osteoblast 
differentiation and postnatal bone growth in osteoblast precursor cells might help promote better 
therapeutic treatments of bone diseases such as osteoporosis.  
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Figure Legends 
Figure 1. Loss of Jab1 in osteoblast precursor cells resulted in progressive dwarfism and 
early lethality. (A) Representative pictures of wild type and Jab1 cKO mice at postnatal days 6, 
12, and 18, displaying the progressive dwarfism. (B) The quantification of the length and weight 
of wild type, Osx-cre only, and Jab1 cKO mice at postnatal day 18. Error bars represent means ± 
SD. ** p < 0.01, *** p < 0.001, ***** p < 0.00005 when Osx-cre only and Jab1 cKO are 
compared with wild type. # p < 0.05 when Jab1 cKO is compared with Osx-cre only. Wild type, 
n = 12; Osx-cre only, n = 8; Jab1 cKO, n = 9.  
Figure 2.   Jab1 cKO mice exhibited severely altered bone morphology and delayed 
secondary ossification center formation. Hematoxylin and Eosin staining in the proximal tibiae 
of wild type, Osx-cre only, and Jab1 cKO mice at 18 days of age. (A) Representative images of 
primary trabeculae. Scale bars, 100µm. (B) Representative images of the secondary ossification 
centers (SOC). Scale bars, 100µm. (C) Representative images of the cortical bone (CB). Scale 
bars, 50µ.   
Figure 3. Jab1 cKO mice exhibited severely altered bone microarchitecture and 
compromised mineralization. (A) The µCT reconstructions of tibiae from Jab1 cKO, wild type, 
and Osx-cre only littermates at 18 days of age. Top row: entire tibiae. White arrow, callus-like 
structure. Second row: the bone present in the first 25% of the metaphysis from the proximal 
tibial growth plate. Third row: cross section taken from box in the second row showing 
trabecular bone inside the metaphysis. Bottom row: cross sections taken at 58% of the diaphyseal 
length from the proximal tibial growth plate. (B) The µCT quantification of the whole tibial 
length. Error bars represent means ± SD. ** p < 0.01 when Osx-cre only and Jab1 cKO are 
compared with wild type. † p < 0.001 when Jab1 cKO is compared with Osx-cre only. Wild 
type, n = 12; Osx-cre only, n = 8; Jab1 cKO, n = 9.  (C) The µCT reconstructions of three 
individual Jab1 cKO tibiae showing the apparent lack of mineralization at the proximal and 
distal ends (white arrows). (D) The µCT reconstruction of the callus-like structure in a Jab1 cKO 
tibia. Left, a rotated view of the Jab1 cKO tibia from 3A with the callus-like structure indicated 
by a white arrow. Right, newly formed bone inside the callus-like structure. 
Figure 4. Loss of Jab1 in osteoblast precursors led to reduced trabecular thickness. (A) The 
µCT quantification of trabecular thickness, trabecular separation, and trabecular number in wild 
type, Osx-cre only, and Jab1 cKO mice. (B) The µCT quantification of bone volume (BV), total 
volume (TV), and trabecular bone volume fraction (BV/TV) in wild type, Osx-cre only, and 
Jab1 cKO mice. Wild type, n = 12; Osx-cre only, n = 8; Jab1 cKO, n = 9. * p < 0.05, ** p < 
0.01, *** p < 0.001 by one-way ANOVA with post-hoc analysis by Bonferroni’s multiple 
comparisons test. 
Figure 5. Loss of Jab1 in osteoblast precursors led to increased cortical thickness and 
cortical bone fraction. (A) The µCT quantification of cortical thickness. (B) The µCT 
quantification of cortical bone area (BA), total cross sectional area (TA), and cortical bone 
fraction (BA/TA). Wild type, n = 12; Osx-cre only, n = 8; Jab1 cKO, n = 9. For parametric 
analyses, * p < 0.05, ** p < 0.01, *** p < 0.001 by one-way ANOVA with post-hoc analysis by 
Bonferroni’s multiple comparisons test. For non-parametric analyses, ### p < 0.001 by Kruskal-
Wallis one-way ANOVA with post-hoc analysis by Dunn’s multiple comparisons test.  
Figure 6. Jab1 deficiency inhibited osteoblast differentiation and mineralization ex vivo. (A) 
Left and middle panels: Jab1 RNA and protein expression levels in control and Jab1-knockdown 
mouse primary calvarial osteoblasts. Right panel: von Kossa staining in control and Jab1-
knockdown mouse primary calvarial osteoblasts after 21 days of culture in osteoblast 
differentiation media. (B) Left and middle panels: Jab1 RNA and protein expression levels in 
control and Jab1-knockdown MC3T3-E1 cells. Right panel: von Kossa staining in Jab1-
knockdown MC3T3-E1 cells after 21 days of culture in osteoblast differentiation media. (C) Left 
and middle panel: Jab1 RNA and protein expression levels in Jab1-knockdown mBMSCs. Right 
panel: oil red O staining of mBMSCs cultures.  
Figure 7. Jab1-knockdown inhibited osteoblast differentiation likely in part through the 
TGFβ/BMP signaling pathways. (A) RNA expression levels of Runx2 and Osteocalcin in Jab1-
knockdown MC3T3-E1 cells. (B) Protein expression levels of Runx2 and Jab1 in Jab1-
knockdown MC3T3-E1 cells. (C) An unbiased reporter screen in Jab1-knockdown MC3T3-E1 
cells. The black arrow indicates a canonical Smad2/3 TGFβ reporter. A detailed list of the 
pathways in this screen can be found in Supplementary Table 3. (D) Western blot analysis of 
Jab1 and phospho-Smad1/5/8 in primary calvarial osteoblasts cultured in osteoblast 
differentiation media for 0 and 21 days, respectively. (E) Western blot analysis of Jab1 and 
phospho-Smad1/5/8 in control and Jab1-knockdown primary calvarial osteoblasts after 21 days 
of culture in osteoblast differentiation media. (F) Western blot analysis of phospho-Smad1/5/8 
(top) and phospho-Smad2/3 (bottom) in control and Jab1-knockdown MC3T3-E1 cells treated 
with 300ng/mL BMP7 or 2ng/mL TGFβ-3  for 1 hour, respectively.  
Highlights 
1. A novel Osx-cre; Jab1flox/flox conditional knockout mouse model exhibits early lethality 
around weaning age. 
 
2. Osx-cre; Jab1flox/flox tibiae display severely impaired bone microarchitecture and 
mineralization. 
  
3. Jab1 in osteoblasts promotes osteoblast differentiation, at least in part through TGFβ and 
BMP signaling.  
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